Autor segons l'article: Martens M; Stierum R; Schymanski EL; Evelo CT; Aalizadeh R; Aladjov H; Arturi K; Audouze K; Babica P; Berka K; Bessems J; Blaha L; Bolton EE; Cases M; Damalas D; Dave K; Dilger M; Exner T; Geerke DP; Grafström R; Gray A; Hancock JM; Hollert H; Jeliazkova N; Jennen D; Jourdan F; Kahlem P; Klanova J; Kleinjans J; Kondic T; Kone B; Lynch I; Maran U; Martinez Cuesta S; Ménager H; Neumann S; Nymark P; Oberacher H; Ramirez N; Remy S; Rocca-Serra P; Salek RM; Sallach B; Sansone SA; Sanz F; Sarimveis H; Sarntivijai S; Schulze T; Slobodnik J; Spjuth O; Tedds J; Thomaidis N; Weber RJM; van Westen GJP; Wheelock CE; Williams AJ; Witters H; Zdrazil B; Županič A; Willighagen EL
Departament: Enginyeria Electrònica, Elèctrica i Automàtica
Autor/s de la URV: Ramírez González, Noelia
Paraules clau: Elixir Fair Interoperability Toxicology
Resum: Toxicology has been an active research field for many decades, with academic, industrial and government involvement. Modern omics and computational approaches are changing the field, from merely disease-specific observational models into target-specific predictive models. Traditionally, toxicology has strong links with other fields such as biology, chemistry, pharmacology and medicine. With the rise of synthetic and new engineered materials, alongside ongoing prioritisation needs in chemical risk assessment for existing chemicals, early predictive evaluations are becoming of utmost importance to both scientific and regulatory purposes. ELIXIR is an intergovernmental organisation that brings together life science resources from across Europe. To coordinate the linkage of various life science efforts around modern predictive toxicology, the establishment of a new ELIXIR Community is seen as instrumental. In the past few years, joint efforts, building on incidental overlap, have been piloted in the context of ELIXIR. For example, the EU-ToxRisk, diXa, HeCaToS, transQST, and the nanotoxicology community have worked with the ELIXIR TeSS, Bioschemas, and Compute Platforms and activities. In 2018, a core group of interested parties wrote a proposal, outlining a sketch of what this new ELIXIR Toxicology Community would look like. A recent workshop (held September 30th to October 1st, 2020) extended this into an ELIXIR Toxicology roadmap and a shortlist of limited investment-high gain collaborations to give body to this new community. This Whitepaper outlines the results of these efforts and defines our vision of the ELIXIR Toxicology Community and how it complements other ELIXIR activities.
Àrees temàtiques: Biochemistry, genetics and molecular biology (all) Biochemistry, genetics and molecular biology (miscellaneous) Biotecnología Ciência da computação Ciências agrárias i Ciências biológicas i Ciências biológicas ii Ciências biológicas iii Economia Farmacia General biochemistry,genetics and molecular biology General immunology and microbiology General medicine General pharmacology, toxicology and pharmaceutics Immunology and microbiology (all) Immunology and microbiology (miscellaneous) Interdisciplinar Matemática / probabilidade e estatística Medicina i Medicina ii Medicina iii Medicina veterinaria Medicine (all) Medicine (miscellaneous) Pharmacology, toxicology and pharmaceutics (all) Pharmacology, toxicology and pharmaceutics (miscellaneous)
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: noelia.ramirez@urv.cat
Data d'alta del registre: 2024-10-12
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Referència a l'article segons font original: F1000research. 10
Referència de l'ítem segons les normes APA: Martens M; Stierum R; Schymanski EL; Evelo CT; Aalizadeh R; Aladjov H; Arturi K; Audouze K; Babica P; Berka K; Bessems J; Blaha L; Bolton EE; Cases M; (2021). ELIXIR and Toxicology: a community in development. F1000research, 10(), -. DOI: 10.12688/f1000research.74502.2
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2021
Tipus de publicació: Journal Publications